EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia

Soo Yeon Jang, Kyung Mook Choi iD

Journal of Endocrinology · 01.09.2024 · 262 (3)

DOI: 10.1530/joe-24-0093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, online erschienen am 24.06.2024. Verfasst von Soo Yeon Jang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Sarcopenia, RANK Ligand, Bone and Bones, Osteoporosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcopenia, which refers to the concomitant presence of osteoporosis and sarcopenia, is expected to increase in the rapidly progressive aging world, with serious clinical implications. However, the pathophysiology of osteosarcopenia has not been fully elucidated, and no optimal treatment specific to osteosarcopenia is available. The RANKL–RANK pathway is widely used as a therapeutic target for osteoporosis. Growing evidence supports the importance of the RANKL–RANK pathway, not only in bone, but also in muscle, and the therapeutic potential of targeting this pathway in muscle diseases has been noted. The muscles and bones closely communicate with each other through various secretory factors called myokines and osteokines. This review covers the roles of the RANKL–RANK pathway in the bone and muscle and their reciprocal interactions. Moreover, we will suggest future directions to move forward for the treatment of osteosarcopenia to prepare for an upcoming aging society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaRANK LigandBone and BonesOsteoporosisSignal TransductionHumansAnimalsMuscle, SkeletalReceptor Activator of Nuclear Factor-kappa BAging

Stichwörter der Autor:innen

RANKLbonecrosstalkmuscleosteosarcopenia

Substanzen

RANK LigandReceptor Activator of Nuclear Factor-kappa BTNFSF11 protein, human

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

ORCID-Profile: Kyung Mook Choi

Zitieren

APA

Jang, S. Y., & Choi, K. M. (2024). Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia. Journal of Endocrinology, 262(3). https://doi.org/10.1530/joe-24-0093

Vancouver

Jang SY, Choi KM. Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia. Journal of Endocrinology. 2024;262(3). doi:10.1530/joe-24-0093

BibTeX
@article{Jang2024,
  author = {Jang, Soo Yeon and Choi, Kyung Mook},
  title = {Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia},
  journal = {Journal of Endocrinology},
  year = {2024},
  volume = {262},
  number = {3},
  doi = {10.1530/joe-24-0093}
}
Kostenlos starten →